Shares of Teva Pharmaceutical (TEVA) jumped 5.31% to $11.30 at 15:46 EST on Thursday, following the last session’s upward trend. NYSE Composite (TEVA) is rising 0.37% to $16,681.27, after three consecutive sessions in a row of losses. This seems, up to now, a somewhat bullish trend trading session today.
Teva Pharmaceutical’s last close was $10.73, 19.32% below its 52-week high of $13.30.
Today’s last reported volume for Teva Pharmaceutical is 11386732 which is 45.7% above its average volume of 7815132.
The company’s growth estimates for the present quarter and the next is 7.3% and 13.8%, respectively.
Teva Pharmaceutical’s Revenue
Year-on-year quarterly revenue growth declined by 8.6%, now sitting on 16.28B for the twelve trailing months.
Teva Pharmaceutical’s last week, last month’s, and last quarter’s current volatility was 0.34%, 0.10%, and 1.85%, respectively.
Teva Pharmaceutical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.72% (last week), 1.40% (last month), and 1.85% (last quarter), respectively.
Teva Pharmaceutical’s Stock Yearly Top and Bottom Value
Teva Pharmaceutical’s stock is valued at $11.30 at 15:46 EST, way under its 52-week high of $13.30 and way higher than its 52-week low of $8.44.
Teva Pharmaceutical’s Moving Average
Teva Pharmaceutical’s value is higher than its 50-day moving average of $10.50 and above its 200-day moving average of $10.87.
More news about Teva Pharmaceutical (TEVA).